Powered by
-
LABD Stock Chart
Historical LABD Prices
DIR DL S&P BIO BEAR Stock Analysis
Rating:
Total Grade:
Analysis Breakdown
| LABD Stock Grade: | |
| Fundamental Grade: | |
| Quantitative Grade: | |
| LABD Earnings | |
| Earnings Growth: | |
| Earnings Momentum: | |
| Earnings Surprises: | |
| Analyst Earnings Revisions: | |
| LABD Financial Information | |
| Sales Growth: | |
| Operating Margin Growth: | |
| Cash Flow: | |
| Return on Equity: | |
DIR DL S&P BIO BEAR Stock: Weekly View
| This Week: | |
|---|---|
| Last Week: | |
| Two Weeks Ago: |
LABD Stock predictions, Articles, and DIR DL S&P BIO BEAR News
- From InvestorPlace
- From the Web
-
Direxion Daily S&P Biotech Bear 3X Shares (LABD): The Quick Guide to LABD - May 8, 2017
Like other leveraged ETFs, Direxion Daily S&P Biotech Bear 3X Shares (LABD) seduces with big potential gains when biotech stocks drop. Continue…
-
Buy Today’s Trump Dump in Biotech Stocks – XBI IBB - January 11, 2017
Biotech stocks and ETFs like iShares' IBB and SPDR's XBI were hammered Wednesday on Donald Trump's drug pricing comments. Opportunity knocks. Continue…
-
Be Careful Before Loving Leveraged Biotech ETFs - October 6, 2015
The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs. Continue…
